Liz Rockett

DexCare Board Advisor and
Director, Kaiser Permanente Ventures

Liz invests in healthcare IT, digital health and tech-enabled services for KP Ventures. She joined the fund in 2015. Prior to KPV, Liz ran health impact investing for Imprint Capital, which was acquired by Goldman Sachs. Liz’s operating background is in product development and customer success at the Advisory Board Company (acquired by Optum), TriZetto, and Outcome (acquired by Quintiles).

She completed undergrad at Princeton, and her MBA and MPH at UC Berkeley. Liz has a longstanding love of all things related to people strategy, team culture and career development.